Physician profile
Aria Fallah
NPI 1376950477
$27,575.58
in general payments reported to CMS, 2019-2025
10 companies · $10K in 2025
The $10K reported for 2025 was more than what 86% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,259 · 2021: $59.41 · 2022: $238 · 2023: $1,847 · 2024: $12K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Food and Beverage: $4,061 · Travel and Lodging: $1,895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $18,062.50 |
| Food and Beverage | $4,061.24 |
| Travel and Lodging | $1,895.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $22,490.67 | 2019-2025 | |
| Brainlab, INC. | $2,121.44 | 2019-2023 | Image Guided Surgical Device |
| Zimmer Biomet Holdings, INC. | $1,292.01 | 2019 | |
| Livanova USA, INC. | $540.25 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Medtronic, INC. | $471.42 | 2025 | Visualase, Percept Pc Brainsense |
| Monteris Medical Corporation | $276.16 | 2023 | Neuroblate |
| Jazz Pharmaceuticals INC. | $175.42 | 2025 | |
| Ucb, INC. | $120.56 | 2022 | |
| Koh Young America, INC. | $53.64 | 2025 | Geniant Cranial |
| Baxter Healthcare | $34.01 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aria Fallah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.